Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO® (miltefosine) Capsules
Go back to Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO® (miltefosine) Capsules| (NASDAQ: ETON) | Delayed: 49.30 -0.89 (1.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.19 | 52 Week High | $ | |||
| Open | $50.93 | 52 Week Low | $ | |||
| Day High | $50.93 | P/E | N/A | |||
| Day Low | $48.66 | EPS | $ | |||
| Volume | 310,031 | |||||



